Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status. J. Can. Res. Updates [Internet]. 2026 Jan. 19 [cited 2026 Jun. 19];15(1):1-10. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/928